Canaccord Genuity Reiterates a 'Hold' on Momenta Pharmaceuticals (MNTA); Q2: First Clarity on Baxter (BAX) Biosimilars Deal
Go back to Canaccord Genuity Reiterates a 'Hold' on Momenta Pharmaceuticals (MNTA); Q2: First Clarity on Baxter (BAX) Biosimilars Deal| Baxter International Inc. (NYSE: BAX) | Delayed: 26.63 +0.69 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.94 | 52 Week High | $50.16 | |||
| Open | $26.04 | 52 Week Low | $34.06 | |||
| Day High | $26.75 | P/E | 7.28 | |||
| Day Low | $25.87 | EPS | $3.66 | |||
| Volume | 2,645,228 | |||||
| Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) | Delayed: 52.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.48 | 52 Week High | $18.32 | |||
| Open | $39.17 | 52 Week Low | $7.86 | |||
| Day High | $52.48 | P/E | N/A | |||
| Day Low | $52.48 | EPS | $-2.13 | |||
| Volume | 147,551 | |||||
